share_log

Puma Biotechnology Q1 2024 Adj EPS $(0.05) Beats $(0.22) Estimate, Sales $43.800M Beat $41.050M Estimate

Benzinga ·  May 2 17:06

Puma Biotechnology (NASDAQ:PBYI) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.22) by 77.27 percent. This is a 155.56 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $43.800 million which beat the analyst consensus estimate of $41.050 million by 6.70 percent. This is a 17.05 percent decrease over sales of $52.800 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment